Pretreatment urinary hormone patterns and survival in patients with breast cancer, prostate cancer, or lung cancer.
D000704:Analysis of Variance; D000728:Androgens / Q000652:urine; D001943:Breast Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000652:urine*; D003404:Creatinine / Q000652:urine; D003937:Diagnosis, Differential; D004967:Estrogens / Q000652:urine; D005260:Female; D005938:Glucocorticoids / Q000652:urine; D006062:Gonadotropins / Q000652:urine; D006728:Hormones / Q000652:urine*; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000652:urine*; D008297:Male; D011276:Pregnanediol / Q000652:urine; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000652:urine*; D011656:Pulmonary Emphysema / Q000175:diagnosis / Q000652:urine; D013256:Steroids / Q000652:urine*
D000728:Androgens; D004967:Estrogens; D005938:Glucocorticoids; D006062:Gonadotropins; D006728:Hormones; D013256:Steroids; D003404:Creatinine; D011276:Pregnanediol